Wockhardt Limited announced that its innovative antibiotic, Zaynich (Zidebactam/Cefepime), demonstrated over 97% clinical efficacy in treating serious infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback